[1] Qiu Y Y, Zhang J, Zeng F Y, et al. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)[J].Pharmacol Res,2023,192:106786. [2] Younossi Z M, Golabi P, Paik J M, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review[J]. Hepatology,2023,77(4):1335-1347. [3] Riazi K, Azhari H, Charette J H, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol,2022,7(9): 851-861. [4] Yip T C, Vilar-Gomez E, Petta S, et al. Geographical similarity and differences in the burden and genetic predisposition of NAFLD[J]. Hepatology,2023,77(4):1404-1427. [5] Harrison S A, Allen A M, Dubourg J, et al. Challenges and opportunities in NASH drug development[J].Nat Med,2023,29(3):562-573. [6] Cigrovski Berkovic M, Bilic-Curcic I, Mrzljak A, et al. NAFLD and physical exercise: ready, steady, go![J]. Front Nutr,2021,8:734859. [7] 程秋雷,吴燕,黄岚,等.中国古代体医融合思想的生成逻辑、历史进程及当代价值意蕴[J].体育研究与教育,2022,37(06):93-96. [8] Lobelo F, Stoutenberg M, Hutber A. The exercise is medicine global health initiative: a 2014 update[J]. Br J Sports Med,2014,48(22):1627-1633. [9] 中华人民共和国中央人民政府. 中共中央 国务院印发 《“健康中国2030”规划纲要》[EB/OL]. (2016-10-25)[2023-04-15]. https://www.gov.cn/xinwen/2016-10/25/content_5124174.htm. [10] 冯晓露,白莉莉,杨京钟,等.“健康中国”视角下体医融合的内涵、特征与路径[J].卫生经济研究,2022,39(7):60-63. [11] 马国栋,刘艳环,高博,等.体医融合:概念、融合路径及保障机制[J].成都体育学院学报,2023,49(1):97-103. [12] 张阳,游永豪,王广磊.“健康中国”背景下体医融合干预慢性病的模式研究[J].卫生经济研究,2021,38(10):23-25+29. [13] 王世强,吕万刚.“健康中国”背景下慢性病防治的体医融合服务模式探索[J].中国慢性病预防与控制,2020,28(10):792-797. [14] 黄晶,王世强,刘晴.日本体医融合健康促进的经验借鉴与启示[J].中国全科医学,2021,24(18):2268-2274. [15] 罗超,李晗冉,田东华,等.体医融合模式下HIIT干预NAFLD的运动方法与效果评价[J].北京师范大学学报(自然科学版),2020,56(1):132-140. [16] 王正珍.运动处方的研究与应用进展[J].体育学研究,2021,35(3):40-49. [17] 钱王子迪,董菲.运动处方师人才培养管理系统设计及实现——基于国家运动处方库构建[J].体育科学研究,2022,26(3):68-74. [18] Chatterjee R, Wolman R. Exercise is medicine: a case study of an exercise prescription clinic in the NHS[J].Br J Gen Pract,2019,69(683):307-308. [19] American College of Sports Medicine.ACSM's Guidelines for exercise testing and prescription[EB/OL]. [2023-04-15]. https://www.acsm.org/education-resources/books/guidelines-exercise-testing-prescription. [20] 李国平,王正珍,郝跃峰.运动处方中国专家共识(2023)[J].中国运动医学杂志,2023,42(1):3-13. [21] 郑永才,贾雯.非酒精性脂肪肝病运动处方的研究进展[J].职业与健康,2020,36(4):569-572+576. [22] Conjeevaram H S, Tiniakos D G. Editorial: exercise for NAFLD: does intensity matter?[J].Am J Gastroenterol,2011,106(3):470-475. [23] Fan J G, Wei L, Zhuang H, et al. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)[J].J Dig Dis,2019,20(4):163-173. [24] Zhou B J, Huang G, Wang W, et al. Intervention effects of four exercise modalities on nonalcoholic fatty liver disease: a systematic review and Bayesian network meta-analysis[J].Eur Rev Med Pharmacol Sci,2021,25(24):7687-7697. [25] Piercy K L, Troiano R P, Ballard R M, et al.The physical activity guidelines for Americans[J]. JAMA,2018,320(19): 2020. [26] 张伟国,卢文云.数字赋能体医融合治理:现实价值、实践困境与推进策略[J].沈阳体育学院学报,2023,42(4):54-61. [27] 张丽,勾钰淞,梁珊,等.体医融合模式管理非酒精性脂肪肝的适用性及效果探讨[J].健康体检与管理,2022,3(1):85-88. [28] Huber Y, Pfirrmann D, Gebhardt I, et al. Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program[J].Aliment Pharmacol Ther,2019,50(8):930-939. [29] Pfirrmann D, Huber Y, Schattenberg J M, et al. Web-based exercise as an effective complementary treatment for patients with nonalcoholic fatty liver disease: intervention study[J]. J Med Internet Res,2019,21(1):e11250. [30] O'Gorman P, Naimimohasses S, Monaghan A, et al. Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention[J].Aliment Pharmacol Ther,2020,52(8):1387-1398. [31] Cheng S, Ge J, Zhao C, et al. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: a randomized controlled trial[J].Sci Rep,2017,21;7(1):15952. [32] 韩磊磊,王艳艳,贺立娥,等.英国运动转介计划的发展经验对我国体医融合的启示[J].西安体育学院学报,2020,37(2):137-144. [33] 高原,寇现娟.体医融合背景下的糖尿病防治:美国经验及启示[J].中国全科医学,2022,25(25):3089-3096. |